Science Explorer Interactive view Map
Topic · Rheumatology

Glycogen Storage Diseases and Myoclonus

Glycogen Storage Diseases and Myoclonus is a research topic within Rheumatology. Science Explorer counts 17k research works in it since 1950. 14.3% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the metabolism of glycogen, particularly in the context of myoclonic disorders such as progressive myoclonus epilepsy and glycogen storage diseases. It explores genetic mutations, neurodegeneration, and the role of the glucose-6-phosphatase system in these conditions, shedding light on diagnosis, management, and potential therapeutic aspects.

  • Glycogen
  • Metabolism
  • Myoclonic Disorders
  • Glycogen Storage Diseases
  • Lafora Disease
  • Glucose-6-Phosphatase System
  • Neurodegeneration
  • Epilepsy
  • Neutrophil Dysfunction
  • Genetic Mutations
Research works
17k
fractional, since 1950
In the world top 10%
2.4k
per year above
Top-10% rate
14.3%
share of its works in the world top 10%
Growth, 2013–17 → 2018–22
+5%
the tick is no change

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Glycogen Storage Diseases and Myoclonus research?

By volume, the United States and China publish the most (528 and 224 works in 2022–2025).

By volume, 2022–2025

  1. 1 United States 528 works
  2. 2 China 224 works
  3. 3 India 152 works
  4. 4 Italy 144 works
  5. 5 Japan 126 works
  6. 6 United Kingdom 98 works
  7. 7 Brazil 93 works
  8. 8 Germany 92 works
  9. 9 France 89 works
  10. 10 Spain 82 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 32.4%China: 13.8%India: 9.4%Italy: 8.8%6 others listed: 35.6%32%largest
United States528 · 32.4%China224 · 13.8%India152 · 9.4%Italy144 · 8.8%6 others listed579 · 35.6%

Shares of the rows listed above, not of the whole node.

Which institutions lead Glycogen Storage Diseases and Myoclonus research?

By volume in 2022–2025, The University of Texas Southwestern Medical Center publishes the most Glycogen Storage Diseases and Myoclonus research, followed by University College London and National Institute of Mental Health and Neurosciences.

By volume, 2022–2025

  1. 1 The University of Texas Southwestern Medical CenterUnited States 12 works
  2. 2 University College LondonUnited Kingdom 11 works
  3. 3 National Institute of Mental Health and NeurosciencesIndia 10 works
  4. 4 Duke UniversityUnited States 8 works
  5. 5 University of FloridaUnited States 8 works
  6. 6 All India Institute of Medical SciencesIndia 8 works
  7. 7 InsermFrance 7 works
  8. 8 Erasmus MCNetherlands 7 works
  9. 9 University Medical Center GroningenNetherlands 7 works
  10. 10 Duke Medical CenterUnited States 7 works

Who are the leading researchers in Glycogen Storage Diseases and Myoclonus?

The most-cited researchers publishing on Glycogen Storage Diseases and Myoclonus include Winfried März, Thomas Schwarz and Michael Weller.

  1. 1 Winfried März Germany 5.2k citations
  2. 2 Thomas Schwarz United States 3.1k citations
  3. 3 Michael Weller Switzerland 2.7k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

Where is Glycogen Storage Diseases and Myoclonus research done?

The largest centres of Glycogen Storage Diseases and Myoclonus research in 2022–2025 are London (United Kingdom), Beijing (China), Paris (France) and Tokyo (Japan). Among places with at least 20 works in it, it is an unusually large share of all research in Durham.

Largest cities, 2022–2025

  1. 1 London United Kingdom 40 works
  2. 2 Beijing China 40 works
  3. 3 Paris France 36 works
  4. 4 Tokyo Japan 34 works
  5. 5 Madrid Spain 26 works
  6. 6 New York United States 26 works
  7. 7 Rome Italy 24 works
  8. 8 São Paulo Brazil 24 works
  9. 9 Shanghai China 21 works
  10. 10 Istanbul Türkiye 21 works

Where it is the local speciality

  1. DurhamUS · 20.3 works7.4×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Glycogen Storage Diseases and Myoclonus than the world average.

See Glycogen Storage Diseases and Myoclonus on the map

Where is the best place to study Glycogen Storage Diseases and Myoclonus?

Among universities, judged by research, University College London and Duke University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

#UniversityScoreTop 10%SpecialisationWorksGrowth
1 University College LondonUnited Kingdom 62.915.2%3.7×11 +57.5%
2 Duke UniversityUnited States 35.78.2%5.2×8 +118.5%

Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.

Is Glycogen Storage Diseases and Myoclonus research growing?

Output in 2018–2022 was 5% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Glycogen Storage Diseases and Myoclonus.

19801990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.